APP’s Granisetron is AP-rated, preservative and latex-free, and bar-coded. Granisetron hydrochloride injection is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high dose cisplatin and radiation cancer therapy. Granisetron hydrochloride injection is also indicated for the prevention of postoperative nausea.